2021
DOI: 10.1021/acs.molpharmaceut.1c00210
|View full text |Cite
|
Sign up to set email alerts
|

Flexibility in Drug Product Development: A Perspective

Abstract: The process of bringing a drug to market involves innumerable decisions to refine a concept into a final product. The final product goes through extensive research and development to meet the target product profile and to obtain a product that is manufacturable at scale. Historically, this process often feels inflexible and linear, as ideas and development paths are eliminated early on to allow focus on the workstream with the highest probability of success. Carrying multiple options early in development is bo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 33 publications
0
2
0
Order By: Relevance
“…Here, we investigated local modeling to automatically identify similar samples within the training set and then establish a fit-for-purpose model to quantify the unloaded cargo concentration and loading capacity in LNP formulations. Recently, other spectroscopy-based modeling approaches have also been investigated for characterizations of LNP systems; for example, a Raman microscopy equipped with PLS analysis showed great potential to characterize LNP compositions . Compared to previous experimental and modeling strategies, our LWR modeling approach may further spare the efforts for multivariate analyses tailored to cargo and lipid species, thereby simplifying the analytical process and better serving the HTS needs.…”
Section: Resultsmentioning
confidence: 99%
“…Here, we investigated local modeling to automatically identify similar samples within the training set and then establish a fit-for-purpose model to quantify the unloaded cargo concentration and loading capacity in LNP formulations. Recently, other spectroscopy-based modeling approaches have also been investigated for characterizations of LNP systems; for example, a Raman microscopy equipped with PLS analysis showed great potential to characterize LNP compositions . Compared to previous experimental and modeling strategies, our LWR modeling approach may further spare the efforts for multivariate analyses tailored to cargo and lipid species, thereby simplifying the analytical process and better serving the HTS needs.…”
Section: Resultsmentioning
confidence: 99%
“…Combinations of these ∼160 approved drugs and ∼350 drug‐like basic molecules with ∼500 approved carboxylic acid drugs in a matrix fashion would provide a huge pool of starting point cocrystals that contain a relatively small number of heterosynthons that have already been optimized for enhanced bioavailability. Two recent papers, one on a pyrimidine drug inhibitor [45] and another on drug product development, [46] as well as the US‐FDA approval of drug–drug cocrystal Seglentis [47] attest to the timeliness of our proposal in the context of accelerating drug discovery and pharmaceutical development.…”
Section: Figurementioning
confidence: 99%